Published online before print August 12, 2002, doi: 10.1161/01.CIR.0000027585.05868.67
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1294.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Stem Cell-Derived Cardiomyocytes Demonstrate Arrhythmic Potential
From the Department of Medicine, Emory University (Y.M.Z., M.N., S.C.D.) and the Atlanta VA Medical Center, Department of Cell Biology (C.H.), Emory University, Atlanta, Ga.
Correspondence to Samuel C. Dudley, Jr, MD, PhD, Division of Cardiology, Emory University/Atlanta VA Medical Center, 1670 Clairmont Rd (111B), Decatur, GA 30033. E-mail sdudley{at}emory.edu
Background— Cardiomyocytes (CMs) derived from pluripotent embryonic stem cells (ESCs) and embryonal carcinoma cells (ECCs) have some but not all characteristics of adult myocytes. ESCs have shown the ability to engraft in areas of myocardial damage, which suggests their use in cell transplantation therapy for cardiomyopathy. We studied the arrhythmogenic properties of CMs differentiated from mouse ESCs and ECCs.
Methods and Results— CMs derived in vitro were studied in the whole-cell patch-clamp mode. CMs from both sources showed action potential (AP) morphology heterogeneity, with reduced maximum upstroke velocities (dV/dt) and prolonged AP durations. CMs demonstrated prolonged, spontaneous electrical activity in culture. Frequent triggered activity was observed with and without pharmacological enhancement. Phase 2 or 3 early afterdepolarizations could be induced easily by Bay K8644 plus tetraethylammonium chloride (TEA) or [TEA]o after Cs+ replacement for [K+]i, respectively. A combination of bradycardic stimulation, hypokalemia, and quinidine resulted in early afterdepolarizations. Delayed afterdepolarizations could be induced easily and reversibly by hypercalcemia or isoproterenol.
Conclusions— ESCs or ECCs differentiated into at least 3 AP phenotypes. CMs showed spontaneous activity, low dV/dt, prolonged AP duration, and easily inducible triggered arrhythmias. These findings raise caution about the use of totipotent ESCs in cell transplantation therapy, because they may act as an unanticipated arrhythmogenic source from any of the 3 classic mechanisms (reentry, automaticity, or triggered activity).
Key Words: cells • arrhythmia • grafting • electrophysiology • cardiomyopathy
This article has been cited by other articles:
 |
|
 |
|
  L. GEPSTEIN Experimental Molecular and Stem Cell Therapies in Cardiac Electrophysiology Ann. N.Y. Acad. Sci., March 1, 2008; 1123(1): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Qu, G. M. Whitaker, L. Hove-Madsen, G. F. Tibbits, and E. A. Accili Hyperpolarization-activated cyclic nucleotide-modulated 'HCN' channels confer regular and faster rhythmicity to beating mouse embryonic stem cells J. Physiol., February 1, 2008; 586(3): 701 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Shang, A. E. Pfahnl, S. Sanyal, Z. Jiao, J. Allen, K. Banach, J. Fahrenbach, D. Weiss, W. R. Taylor, A. M. Zafari, et al. Human Heart Failure Is Associated With Abnormal C-Terminal Splicing Variants in the Cardiac Sodium Channel Circ. Res., November 26, 2007; 101(11): 1146 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kehat and L. Gepstein Electrophysiological Coupling of Transplanted Cardiomyocytes Circ. Res., August 31, 2007; 101(5): 433 - 435. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fukushima, A. Varela-Carver, S. R. Coppen, K. Yamahara, L. E. Felkin, J. Lee, P. J.R. Barton, C. M.N. Terracciano, M. H. Yacoub, and K. Suzuki Direct Intramyocardial But Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure Model Circulation, May 1, 2007; 115(17): 2254 - 2261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Gaudette and I. S. Cohen Cardiac Regeneration: Materials Can Improve the Passive Properties of Myocardium, but Cell Therapy Must Do More Circulation, December 12, 2006; 114(24): 2575 - 2577. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ben-Dor, S. Fuchs, and R. Kornowski Potential Hazards and Technical Considerations Associated With Myocardial Cell Transplantation Protocols for Ischemic Myocardial Syndrome J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1519 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-R. Li, X.-L. Deng, H. Sun, S. S.M. Chung, H.-F. Tse, and C.-P. Lau Ion Channels in Mesenchymal Stem Cells from Rat Bone Marrow Stem Cells, June 1, 2006; 24(6): 1519 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Goette, K. Jentsch-Ullrich, M. Hammwohner, S. Trautmann, A. Franke, H. U. Klein, and A. Auricchio Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy. Europace, March 1, 2006; 8(3): 157 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ince, M. Petzsch, H. D. Kleine, H. Schmidt, T. Rehders, T. Korber, C. Schumichen, M. Freund, and C. A. Nienaber Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony-Stimulating Factor (FIRSTLINE-AMI) Circulation, November 15, 2005; 112(20): 3097 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Dudley Jr Beware of Cells Bearing Gifts: Cell Replacement Therapy and Arrhythmic Risk Circ. Res., July 22, 2005; 97(2): 99 - 101. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Rastan, T. Walther, M. Kostelka, J. Garbade, A. Schubert, A. Stein, S. Dhein, and F. W. Mohr Morphological, electrophysiological and coupling characteristics of bone marrow-derived mononuclear cells--an in vitro-model Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson Genes, stem cells and biological pacemakers Cardiovasc Res, October 1, 2004; 64(1): 12 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Lee and R. R. Makkar Stem-Cell Transplantation in Myocardial Infarction: A Status Report Ann Intern Med, May 4, 2004; 140(9): 729 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Heubach, E. M. Graf, J. Leutheuser, M. Bock, B. Balana, I. Zahanich, T. Christ, S. Boxberger, E. Wettwer, and U. Ravens Electrophysiological properties of human mesenchymal stem cells J. Physiol., February 1, 2004; 554(3): 659 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Makkar, M. Lill, and P.-S. Chen Stem cell therapy for myocardial repair: Is it arrhythmogenic? J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2070 - 2072. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Zhang, L. Shang, C. Hartzell, M. Narlow, L. Cribbs, and S. C. Dudley Jr. Characterization and regulation of T-type Ca2+ channels in embryonic stem cell-derived cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2770 - H2779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goette, K. Jentsch-Ullrich, U. Lendeckel, C. Rocken, M. Agbaria, A. Auricchio, M. Mohren, A. Franke, and H. U. Klein Effect of Atrial Fibrillation on Hematopoietic Progenitor Cells: A Novel Pathophysiological Role of the Atrial Natriuretic Peptide? Circulation, November 18, 2003; 108(20): 2446 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Forrester, M. J. Price, and R. R. Makkar Stem Cell Repair of Infarcted Myocardium: An Overview for Clinicians Circulation, September 2, 2003; 108(9): 1139 - 1145. [Full Text] [PDF]
|
|
|
|
|
|
G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li Cell transplantation to improve ventricular function in the failing heart Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Raman, G. E. Cooke, P. F. Binkley, S. C. Dudley Jr, M. Narlow, Y. M. Zhang, and C. Hartzell Stem Cell-Derived Cardiomyocytes Demonstrate Arrhythmic Potential * Response Circulation, May 27, 2003; 107(20): e195 - 195. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Fijnvandraat, R. H. Lekanne Deprez, and A. F.M. Moorman Development of heart muscle-cell diversity: a help or a hindrance for phenotyping embryonic stem cell-derived cardiomyocytes Cardiovasc Res, May 1, 2003; 58(2): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Goldenthal and J. Marin-Garcia Stem cells and cardiac disorders: an appraisal Cardiovasc Res, May 1, 2003; 58(2): 369 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Strauer and R. Kornowski Stem Cell Therapy in Perspective Circulation, February 25, 2003; 107(7): 929 - 934. [Full Text] [PDF]
|
|
|
|
|
|
E. C. Perin, Y.-J. Geng, and J. T. Willerson Adult Stem Cell Therapy in Perspective Circulation, February 25, 2003; 107(7): 935 - 938. [Full Text] [PDF]
|
|